NCT00991224 - Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

HIV Infections

Interventions

BIOLOGICAL

WT-gag-TCR modified T cells

Single dose of WT-gag-TCR modified T cells infused over 3 consecutive days.

BIOLOGICAL

α/6-gag-TCR modified T cells

Single dose of WT-gag-TCR modified T cells infused over 3 consecutive days.

OTHER

STI or Drug Holiday

Subjects will stop taking antiviral medications for 16 weeks.

Trial Locations (1)

University of Pennsylvania, Philadelphia